Showing results 1 to 20 of 51
next >
| Issue Date | Title | Author(s) |
| 2021-08-10 | The parasite-derived peptide FhHDM-1 activates the PI3K/Akt pathway to prevent cytokine-induced apoptosis of β-cells. | Camaya, I; Mok, TY; Lund, M; To, J; Braidy, N; Robinson, MW; Santos, J; O'Brien, B; Donnelly, S |
| 2021-01-11 | Complementary transcriptomic and proteomic analyses reveal the cellular and molecular processes that drive growth and development of Fasciola hepatica in the host liver | Cwiklinski, K; Robinson, MW; Donnelly, S; Dalton, JP |
| 2019-01-01 | The cathepsin-like cysteine peptidases of trematodes of the genus Fasciola | Cwiklinski, K; Donnelly, S; Drysdale, O; Jewhurst, H; Smith, D; De Marco Verissimo, C; Pritsch, IC; O'Neill, S; Dalton, JP; Robinson, MW |
| 2018-04-01 | Infection by the helminth parasite fasciola hepatica requires rapid regulation of metabolic, virulence, and invasive factors to adjust to its mammalian host | Cwiklinski, K; Jewhurst, H; McVeigh, P; Barbour, T; Maule, AG; Tort, J; O'Neill, SM; Robinson, MW; Donnelly, S; Dalton, JP |
| 2017-01-01 | The immune modulatory peptide FhHDM-1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophages | Alvarado, R; To, J; Lund, ME; Pinar, A; Mansell, A; Robinson, MW; O'Brien, BA; Dalton, JP; Donnelly, S |
| 2016-11-24 | A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis | Lund, ME; Greer, J; Dixit, A; Alvarado, R; McCauley-Winter, P; To, J; Tanaka, A; Hutchinson, AT; Robinson, MW; Simpson, AM; O'Brien, BA; Dalton, JP; Donnelly, S |
| 2016-09-09 | Unexpected activity of a novel kunitz-type inhibitor Inhibition of cysteine proteases but not serine proteases | Smith, D; Tikhonova, IG; Jewhurst, HL; Drysdale, OC; Dvořák, J; Robinson, MW; Cwiklinski, K; Dalton, JP |
| 2015-12-01 | The extracellular vesicles of the helminth pathogen, Fasciola hepatica: Biogenesis pathways and cargo molecules involved in parasite pathogenesis | Cwiklinski, K; De La Torre-Escudero, E; Trelis, M; Bernal, D; Dufresne, PJ; Brennan, GP; O'Neill, S; Tort, J; Paterson, S; Marcilla, A; Dalton, JP; Robinson, MW |
| 2014-01-21 | Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse | Lund, ME; O'Brien, BA; Hutchinson, AT; Robinson, MW; Simpson, AM; Dalton, JP; Donnelly, S |
| 2013-08-29 | Trematode Cysteine Endopeptidases | Robinson, MW; Brindley, PJ; McKerrow, JH; Dalton, JP |
| 2013-08-01 | Immunomodulatory molecules of Fasciola hepatica: Candidates for both vaccine and immunotherapeutic development | Dalton, JP; Robinson, MW; Mulcahy, G; O'Neill, SM; Donnelly, S |
| 2013-01-01 | Fasciola hepatica: The therapeutic potential of a worm secretome | Robinson, MW; Dalton, JP; O'Brien, BA; Donnelly, S |
| 2013-01-01 | Helminth defence molecules-immunomodulators designed by parasites! | Robinson, MW; Donnelly, S; Dalton, JP |
| 2013-01-01 | Cathelicidin-like Helminth Defence Molecules (HDMs): Absence of Cytotoxic, Anti-microbial and Anti-protozoan Activities Imply a Specific Adaptation to Immune Modulation | Thivierge, K; Cotton, S; Schaefer, DA; Riggs, MW; To, J; Lund, ME; Robinson, MW; Dalton, JP; Donnelly, SM |
| 2013-01-01 | MHJ-0125 is an M42 glutamyl aminopeptidase that moonlights as a multifunctional adhesin on the surface of Mycoplasma hyopneumoniae | Robinson, MW; Buchtmann, KA; Jenkins, C; Tacchi, JL; Raymond, BBA; To, J; Chowdhury, PR; Woolley, LK; Labbate, M; Turnbull, L; Whitchurch, CB; Padula, MP; Djordjevic, SP |
| 2012-12-01 | Defense peptides secreted by helminth pathogens: Antimicrobial and/or immunomodulator molecules? | Cotton, S; Donnelly, S; Robinson, MW; Dalton, JP; Thivierge, K |
| 2012-12-01 | Antimicrobial peptides: Utility players in innate immunity | Robinson, MW; Hutchinson, AT; Donnelly, S |
| 2012-11-01 | A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase | Robinson, MW; Alvarado, R; To, J; Hutchinson, AT; Dowdell, SN; Lund, M; Turnbull, L; Whitchurch, CB; O'Brien, BA; Dalton, JP; Donnelly, S |
| 2012-08-23 | Mechanisms of Immune Modulation by Fasciola hepatica: Importance for Vaccine Development and for Novel Immunotherapeutics | Robinson, MW; Dalton, JP; O'Neill, SM; Donnelly, SM |
| 2012-04-01 | Fasciola hepatica virulence-associated cysteine peptidases: A systems biology perspective | McVeigh, P; Maule, AG; Dalton, JP; Robinson, MW |
